Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

NCT05066165 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped Pivoting to an allogeneic version of this program currently in preclinical development.

Conditions

Interventions

Sponsor

Intellia Therapeutics